Home › NDC Lookup › RxCUI directory › RxCUI 1944376

24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri] — RxCUI 1944376

RxNorm drug concept · Semantic branded drug
RxCUI 1944376 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1944376
Official name24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Gocovri 137 MG Extended Release Oral Capsule; GOCOVRI 137 MG 24HR Extended Release Oral Capsule; Gocovri 137 MG (as amantadine HCl 170 MG) 24 HR Extended Release Oral Capsule
FDA products mapped4
Package NDCs mapped10
Reported Medicaid activity (SDUD)1,026 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amantadine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amantadine only works against influenza A — it won't help with influenza B, COVID-19, colds, or stomach bugs. And it works best for the flu when you start it early in the illness....
  • Can I take amantadine to treat a regular flu or a stomach bug?
  • The ones that matter most are hallucinations (seeing or hearing things that aren't there), significant dizziness — especially when you stand up — and any vision changes like sudden...
  • I take amantadine for Parkinson's — what side effects should I actually watch for?
📖 Read our full Amantadine guide →

🕸️ Concept Web — How 24 HR amantadine 137 MG Extended Release Oral Ca... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR amantadine 137 MG Extended Release Oral Capsule [Gocovri] RxCUI 1944376

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Amantadine 620
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Gocovri 1944371
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amantadine Extended Release Oral Capsule 1944369
    • Amantadine Oral Product 1151229
    • Amantadine Pill 1151230
    • Amantadine Extended Release Oral Capsule [Gocovri] 1944373
    • Gocovri Oral Product 1944374
    • Gocovri Pill 1944375
    • Extended Release Oral Capsule 316943
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Amantadine 137 MG [Gocovri] SBDC · 1944372
  • Amantadine Extended Release Oral Capsule [Gocovri] SBDF · 1944373
  • Gocovri Oral Product SBDG · 1944374
  • Gocovri Pill SBDG · 1944375
  • Gocovri BN · 1944371

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 1944376 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
17772-0085-21 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-085-21) GOCOVRI Supernus Pharmaceuticals 2017-08-24
17772-0085-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-085-60) GOCOVRI Supernus Pharmaceuticals 2017-08-24
17772-0170-21 21 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-21) GOCOVRI Supernus Pharmaceuticals 2017-08-24
17772-0170-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (17772-170-60) GOCOVRI Supernus Pharmaceuticals 2017-08-24
70482-0085-21 21 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-21) GOCOVRI Adamas Pharma, LLC 2017-08-24
70482-0085-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-60) GOCOVRI Adamas Pharma, LLC 2017-08-24
70482-0085-61 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-085-61) GOCOVRI Adamas Pharma, LLC 2017-08-24
70482-0170-21 21 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-21) GOCOVRI Adamas Pharma, LLC 2017-08-24
70482-0170-60 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-60) GOCOVRI Adamas Pharma, LLC 2017-08-24
70482-0170-61 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-61) GOCOVRI Adamas Pharma, LLC 2017-08-24
Observed labelers: Adamas Pharma, LLC (6) · Supernus Pharmaceuticals (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.